CLINICAL_TRIALS
trial_result
· 2015-11-26
Clinical Trial Update: A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing [Phase 3]
Summary
Phase 3 long-term dosing study of fluoxetine in adults with Major Depressive Disorder completed, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-11-26